| Term 
 
        | Acetazolamide (Diamox) - mechanism only |  | Definition 
 
        | PCT diuretic; Carbonic anhydrase inhibitor; HCO3- loss in urine; urine is alkaline; increase excretion of NaCl and H2O. |  | 
        |  | 
        
        | Term 
 
        | Acetazolamide (Diamox) - Tx |  | Definition 
 
        | Glaucoma, cysteinuria (increased solubility in alkaline urine), seizures (decreases pH of blood), occasionally liver cirrhosis & renal failure |  | 
        |  | 
        
        | Term 
 
        | Acetazolamide (Diamox) - Side Fx |  | Definition 
 
        | metabolic acidosis, hyperchloremia, drowsiness, increased sensitivity to thiazides |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Osmotic diuretic - 10x increase in urine flow; primary site of action is PCT; Prevents H2O from leaving the tubule which results in backflow of cations and more H2O; Inert |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prophy for ARF with low GFR (i.e trauma, shock); Side FX include volume overload & possible heart failure |  | 
        |  | 
        
        | Term 
 
        | Loop Diuretics - mechanism |  | Definition 
 
        | inhibit Na-K-2Cl symport; increase renin; maintain GFR; causes increased diuresis with NaCl losses; venodilators; |  | 
        |  | 
        
        | Term 
 
        | Loop Diuretics - Tx / Side FX |  | Definition 
 
        | Tx - edema, hypercalcemia, washout toxins, prophylaxis for renal failure, HTN in combo; Side Fx - increase BUN, hypokalemia, alkalosis, ototoxicity, drug interactions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Loop diuretic; inhibits NaCl resorption; high safety margin; interacts with Warfarin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Loop Diuretic; 40x more potent than furosemide; no Warfarin interaction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Loop diuretic with long half-life; Once daily dosing |  | 
        |  | 
        
        | Term 
 
        | Thiazide diuretics - mechanism |  | Definition 
 
        | DCT diuretics; Na/Cl symport inhibition in Na-K- Aldo independent segment, cause natriuresis and diuresis along with other fx. Decrease Ca2+ in urine |  | 
        |  | 
        
        | Term 
 
        | Thiazide diuretics - short term fx |  | Definition 
 
        | diuresis, hypokalemia, decrease CO and BP |  | 
        |  | 
        
        | Term 
 
        | Thiazide diuretics - long term fx |  | Definition 
 
        | decrease hypervolemia and direct vasodilation |  | 
        |  | 
        
        | Term 
 
        | Thiazide diuretics - side fx |  | Definition 
 
        | hyperuricemia (gout risk), hypercholesterolemia, hypercalcemia, hypokalemia, hypo-Mg, other in slide deck |  | 
        |  | 
        
        | Term 
 
        | Hydrocholorthiazide (Esidrex) |  | Definition 
 
        | Class 1 Thiazide diuretic (use when GFR>40ml/min) short acting; tx HTN, nephrogenic diabetes insipidus |  | 
        |  | 
        
        | Term 
 
        | Chlorthialidone (Hygroton) |  | Definition 
 
        | Class 1 Thiazide diuretic (use when GFR >40ml/min) long acting |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class 1 (use when GFR > 40ml/min) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class II (used when GFR 20-40ml/min); increased potency, tx HTN even with renal insufficiency |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class II (used when GRF 20-40ml/min);highly potent; tx HTN, and has direct vasodilatory fx |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit Na resorption in DCT. Used with HCTZ to normalize K+ |  | 
        |  | 
        
        | Term 
 
        | Spironolactone (Aldactone) |  | Definition 
 
        | K+ sparing diuretic; aldosterone antagonist, competitive inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | K+ sparing diuretic; aldosterone antagonist |  | 
        |  | 
        
        | Term 
 
        | Amiloride (Midamor) & Triamterene (Dyrenium) |  | Definition 
 
        | K+ sparing diuretic; used with HCTZ; Side fx include hypekalemia and anemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | acts on 2 receptors- V1- vasopressor (via IP3 and Ca2+release) , V2 - activates aquaporin to increase H2O readsorption |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-diuretic; V2 receptor agonist, tx central diabetes insipidus and bleeding |  | 
        |  | 
        
        | Term 
 
        | Demeclocyline (Declocylcin) |  | Definition 
 
        | Anti-ADH, pro-diuretic; use with OPC-31260; antagonize ADH at V2 receptors; Tx Sydrome of inappropriate ADH Secretion |  | 
        |  | 
        
        | Term 
 
        | How to manage diuertic induced metabolic alkalosis (a) in patients w/o heart failure and (b) in patients w/ heart failure |  | Definition 
 
        | (a) K+ replacement and restoration of volume with NS. (b) NS is contraindicated in these patients, tx with actezolamide |  | 
        |  | 
        
        | Term 
 
        | Serious toxicity of diuretic use in cardiac patients and how to manage |  | Definition 
 
        | Hypokalemia; manage by reducing Na+ intake to decrease Na+ delivery to the K+ secreting collecting tubule; non compliant patients must take oral KCl or a K+ sparing diuretic |  | 
        |  |